Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitors
This preliminary study confirms the utility of flow cytometry for monitoring the biological effects of JAKinibs. Further studies on treated patients are now required to evaluate the clinical value of these two flow cytometry panels.
Authors
- Xavier Roblin (ORCID: https://orcid.org/0000-0002-7929-4878)
- Anne‐Emmanuelle Berger (ORCID: https://orcid.org/0000-0001-5598-7509)
- Louis Waeckel (ORCID: https://orcid.org/0000-0002-4941-2415)
- Stéphane Paul (ORCID: https://orcid.org/0000-0002-8830-4273)
- Chloé Talon
- Mathilde Barrau
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Centre Hospitalier Universitaire de Saint-Étienne (FR)
- Centre International de Recherche en Infectiologie (FR)
Publication Details
- Journal
- Immunotherapy Advances
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1093/immadv/ltaf006
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00